PMID: Genes Environ. 2020 ;42:13. Epub 2020 Mar 11. PMID: 32175033 Abstract Title: Bisphenol A enhances adipogenic signaling pathways in human mesenchymal stem cells. Abstract: Background: The endocrine disruptor Bisphenol-A (BPA), has been involved in dysregulating adipose tissue development and increasing the risk of obesity. The objective of this experiment was to investigate whether treatment …
Author Archives: Taylor Mercado
Level of bisphenol A in follicular fluid and serum and oocyte morphology in patients undergoing IVF treatment.
PMID: J Family Reprod Health. 2019 Sep ;13(3):154-159. PMID: 32201490 Abstract Title: Level of Bisphenol A in Follicular Fluid and Serum and Oocyte Morphology in Patients Undergoing IVF Treatment. Abstract: To assess the correlation between the levels of BPA in the serum and follicular fluid (FF) using oocyte morphology.In this cross-sectional research, oocyte, FF, and …
Peanut sprout extracts cultivated with Fermented sawdust medium inhibits benign prostatic hyperplasia.
PMID: World J Mens Health. 2020 Mar 19. Epub 2020 Mar 19. PMID: 32202087 Abstract Title: Peanut Sprout Extracts Cultivated with Fermented Sawdust Medium Inhibits Benign Prostatic Hyperplasiaand. Abstract: PURPOSE: In this study, we tested whether the resveratrol-enriched peanut sprout extracts cultivated with fermented sawdust medium (PSEFS) could suppress benign prostatic hyperplasia (BPH)and.MATERIALS AND METHODS: …
Resveratrol inhibits ACHN cells via regulation of histone acetylation.
PMID: Pharm Biol. 2020 Dec ;58(1):231-238. PMID: 32202448 Abstract Title: Resveratrol inhibits ACHN cells via regulation of histone acetylation. Abstract: The relationship between resveratrol and histone acetylation in renal cell carcinoma (RCC) has not yet been reported.To explore the functional role of resveratrol in RCC.Functional experiments were performed to determine proliferatio n of ACHN cells …
Continue reading “Resveratrol inhibits ACHN cells via regulation of histone acetylation.”
This comprehensive body of evidence suggests that extracts of hibiscus sabdariffa are promising as a treatment of hypertension and hyperlipidemia.
PMID: Fitoterapia. 2013 Mar ;85:84-94. Epub 2013 Jan 17. PMID: 23333908 Abstract Title: Hibiscus sabdariffa L. in the treatment of hypertension and hyperlipidemia: a comprehensive review of animal and human studies. Abstract: The effectiveness of Hibiscus sabdariffa L. (HS) in the treatment of risk factors associated with cardiovascular disease is assessed in this review by …
Bergamot polyphenols improve dyslipidemia and pathophysiological features in a mouse model of non-alcoholic Fatty liver disease.
PMID: Sci Rep. 2020 Feb 13 ;10(1):2565. Epub 2020 Feb 13. PMID: 32054943 Abstract Title: Bergamot Polyphenols Improve Dyslipidemia and Pathophysiological Features in a Mouse Model of Non-Alcoholic Fatty Liver Disease. Abstract: There is a need for continued drug development for nonalcoholic steatohepatitis (NASH). Bergamot is a plant whose fruit juice is enriched with flavonoids …
Astragaloside IV relieves gestational diabetes mellitus in genetic mice through reducing hepatic gluconeogenesis.
PMID: Can J Physiol Pharmacol. 2020 Mar 11. Epub 2020 Mar 11. PMID: 32160476 Abstract Title: Astragaloside IV relieves gestational diabetes mellitus in genetic mice through reducing hepatic gluconeogenesis. Abstract: Background The glucose intolerance developed during pregnancy is called gestational diabetes mellitus (GDM). GDM has become a severe risk for the health of both mother …
Astragalus polysaccharides inhibits ovarian cancer cell growth via microRNA-27a/FBXW7 signaling pathway.
PMID: Biosci Rep. 2020 Mar 11. Epub 2020 Mar 11. PMID: 32159214 Abstract Title: Astragalus polysaccharides inhibits ovarian cancer cell growth via microRNA-27a/FBXW7 signaling pathway. Abstract: Astragalus polysaccharide (APS), a natural anti-oxidant found in Astragalus membranaceus emerging as a novel anticancer agent, exerts antiproliferative and pro-apoptotic activity in various cancer cell types, but its effect …
This paper reviews recent advances in experimental studies on the effects of Astragalus polysaccharides in treating diabetes mellitus.
PMID: J Tradit Chin Med. 2019 Feb ;39(1):133-138. PMID: 32186034 Abstract Title: Effect of Astragalus polysaccharide in treatment of diabetes mellitus: a narrative review. Abstract: Diabetes mellitus is a chronic endocrine/metabolism disease characterized by hyperglycemia arising from defects in insulin action, insulin secretion, or both. Diabetes mellitus is often complicated by visceral lesions, which can …
Selenized astragalus polysaccharide may be a candidate drug for the treatment and prevention of kidney stones.
PMID: Mater Sci Eng C Mater Biol Appl. 2020 May ;110:110732. Epub 2020 Feb 6. PMID: 32204043 Abstract Title: Preparation and characterization of selenized Astragalus polysaccharide and its inhibitory effect on kidney stones. Abstract: Astragalus polysaccharide (APS) was modified using the NaSeO/HNOmethod to obtain selenized APS (Se-APS) with a selenium content of 1.75 mg/g. The structure …
Health Time 